HI
ARKG icon

Horizon Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Horizon Investments’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Sell
300
-300
-50% -$9.55K ﹤0.01% 1199
2026
Q1 		$15.9K Buy
600
+300
+100% +$8.79K ﹤0.01% 1180
2025
Q4 		$8.69K Hold
300
– – ﹤0.01% 1172
2025
Q3 		$8.33K Buy
300
+100
+50% +$2.53K ﹤0.01% 1043
2025
Q2 		$4.87K Buy
+200
New +$4.38K ﹤0.01% 1004

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Horizon Investments's ARKG Position: Q2 2026 in Review

Horizon Investments reduced its ARK Genomic Revolution ETF (ARKG) stake by 50% in Q2 2026, selling an estimated $9.55K and leaving 300 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Horizon Investments first reported a position in ARKG in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.9K in Q1 2026. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Horizon Investments held 300 shares of ARK Genomic Revolution ETF worth $12.6K as of Q2 2026.
  • Horizon Investments sold 300 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $9.55K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Horizon Investments's portfolio in Q2 2026, its #1199 holding.
  • Horizon Investments first reported a position in ARK Genomic Revolution ETF in Q2 2025 and has held it in 5 quarters since.
  • Horizon Investments's ARK Genomic Revolution ETF position peaked at $15.9K in Q1 2026.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.